MA49478A - Nouveaux conjugués de montélukast et de peptides - Google Patents

Nouveaux conjugués de montélukast et de peptides

Info

Publication number
MA49478A
MA49478A MA049478A MA49478A MA49478A MA 49478 A MA49478 A MA 49478A MA 049478 A MA049478 A MA 049478A MA 49478 A MA49478 A MA 49478A MA 49478 A MA49478 A MA 49478A
Authority
MA
Morocco
Prior art keywords
montelukast
peptides
new conjugates
conjugates
new
Prior art date
Application number
MA049478A
Other languages
English (en)
Other versions
MA49478B1 (fr
Original Assignee
Jiangyin Usun Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangyin Usun Pharmaceutical Co Ltd filed Critical Jiangyin Usun Pharmaceutical Co Ltd
Priority claimed from PCT/CN2019/105832 external-priority patent/WO2020052677A1/fr
Publication of MA49478A publication Critical patent/MA49478A/fr
Publication of MA49478B1 publication Critical patent/MA49478B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MA49478A 2018-09-14 2019-09-14 Nouveaux conjugués de montélukast et de peptides MA49478B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2018105703 2018-09-14
PCT/CN2019/105832 WO2020052677A1 (fr) 2018-09-14 2019-09-14 Nouveaux conjugués de montélukast et de peptides

Publications (2)

Publication Number Publication Date
MA49478A true MA49478A (fr) 2020-03-19
MA49478B1 MA49478B1 (fr) 2023-06-28

Family

ID=87758679

Family Applications (1)

Application Number Title Priority Date Filing Date
MA49478A MA49478B1 (fr) 2018-09-14 2019-09-14 Nouveaux conjugués de montélukast et de peptides

Country Status (1)

Country Link
MA (1) MA49478B1 (fr)

Also Published As

Publication number Publication date
MA49478B1 (fr) 2023-06-28

Similar Documents

Publication Publication Date Title
EP3678705A4 (fr) Nouveaux conjugués de montélukast et de peptides
IL268781A (en) Cd80 variant immunomodulatory proteins and uses thereof
IL272085A (en) Multimeric t-cell modulatory polypeptides and methods of use thereof
IL279897A (en) Fusosome compositions and uses thereof
IL290698A (en) Maytansinoid derivatives with self–immolative peptide linkers and conjugates thereof
PL3694529T3 (pl) Trójswoiste białka i sposoby zastosowania
DK3820894T3 (da) Mesothelin- og cd137-bindende molekyler
EP3752534A4 (fr) Anticorps de glypicane 3 et leurs conjugués
EP3471749A4 (fr) Méthodes et compositions de détection de protéines cibles
PT3468990T (pt) Anticorpos anti-c5 e utilizações dos mesmos
PL3484916T3 (pl) Przeciwciała swoiste wobec hiperfosforylowanego białka tau i sposoby ich zastosowania
EP3684806A4 (fr) Nouveaux anticorps anti-cd3epsilon
IL270595B1 (en) Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
EP3845532A4 (fr) Dérivé de quinolino-pyrrolidin-2-one et application associée
EP3749357A4 (fr) Composition de conjugués polysaccharide-protéine pneumococcique multivalents
PT3697810T (pt) Proteínas imunomoduladoras de ligandos icos variantes e composições e métodos relacionados
EP3383917A4 (fr) Nouveaux anticorps anti-claudine et méthodes d'utilisation
EP3890028A4 (fr) Panneau d'affichage et terminal
PL3558391T3 (pl) Immunokoniugaty skierowane wobec białka adam9 i sposoby ich stosowania
EP3596126A4 (fr) Nouveaux anticorps anti-trkb
IL282282A (en) Immunomodulating polynucleotide conjugates and methods of use
PT3710485T (pt) Conjugados de fármaco e anticorpo anti-sez6 e métodos de utilização
MA43717A (fr) Anticorps anti-tnf et fragments fonctionnels de ceux-ci
EP3632933A4 (fr) Nouveaux anticorps anti-cd40 et leur utilisation
PL3720875T3 (pl) Peptydy przeciwdrobnoustrojowe i sposoby ich stosowania